skip to Main Content
Cannabis industry in regulatory crosshairs

A recent U.S. Department of Treasury Inspector General report suggests that an increase in tax enforcement measures for the legal marijuana (cannabis) industry are imminent, with or without a corresponding increase in IRS guidance.

The legal cannabis industry has expanded prodigiously over the last decade and, as of 2020, a majority of states now allow the sale of cannabis for both medical and recreational uses. What was once primarily an underground enterprise is now an open, multi-billion-dollar industry, with sales expected to nearly double by 2025.

However, despite the increasing acceptance of legal cannabis at the state level, and skyrocketing sales, problems related to taxation remain. For example, while legal cannabis businesses are obligated to pay federal income taxes, cannabis itself remains a Schedule I Controlled Substance. This presents a number of issues, both with payment processing (cannabis businesses still rely heavily on cash as they generally cannot accept credit cards or rely on the traditional banking system) and taxation (a perception of underreporting and a lack of governmental guidance for full compliance). Legislative efforts aimed at ameliorating certain cannabis-related business challenges, such as the Secure and Fair Enforcement (“SAFE”) Banking Act,1have as of yet not generated sufficient political support to become law.

In pertinent part, under Internal Revenue Code (“I.R.C”) Section 61, businesses, including those in the cannabis industry, are obligated to report all income, regardless of source or legality. Yet, I.R.C. Section 280E prohibits deductions and credits “for any amount paid or incurred during the taxable year in carrying on any trade or business if such trade or business (or the activities which comprise such trade or business) consists of trafficking in controlled substances.” [Read More @ Nixon Peabody]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

Kentucky’s Medical Cannabis Program Undergoes Dramatic Transformation: Navigating HB 829 and the Emergency Licensing Regulations

By Hannah King and Arin Aragona Plans for Kentucky’s medical cannabis program took a significant turn last week with the passage of House Bill 829 and the implementation of emergency…

Cannabis in Court: When Federal Courts Will Hear Commercial Disputes Related to the Cannabis Business

By Steven Ascher and Anna M.Windemuth The unique status of the cannabis business —  legal in a majority of states, but still illegal under federal law — creates a thorny…

Patchwork Regulation of CBD Products Continues Despite Rise in Demand

By Courtney A. Hunter and Jessalyn H. Zeigler Demand for cannabidiol (CBD) products continues to climb, and the market has risen to the occasion. There is now a robust array…

How Private Equity Trumped Social Equity in State Cannabis Deal

Confidential documents obtained by THE CITY reveal how Chicago Atlantic Group became one of the biggest beneficiaries of the state’s legalization program. Last June, Gov. Kathy Hochul announced that a…

More Categories

Back To Top
×Close search
Search